| Gene symbol | CD33 | Synonyms | CD33rSiglec, SIGLEC-3, SIGLEC3, p67 | Type of gene | protein-coding |
| Chromosome | 19 | Map location | 19q13.41 | dbXrefs | |
| Gene perturbation-related omics dataset | PerturbAtlas | ||||
| Description | CD33 molecule | ||||
| GTO ID | GTC0745 |
| Trial ID | ChiCTR1800017290 |
| Disease | Acute Myeloid Leukemia |
| Altered gene | CD33 |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | CD33 CAR-T cells |
| Co-treatment | allo-HSCT |
| Phase | Early_Phase1 |
| Recruitment status | Recruiting |
| Title | CD33 CAR T–cell therapy for acute myelogenous leukemia(relapse/refractory) |
| Year | 2018 |
| Country | China |
| Company sponsor | Tianjin First Central Hospital |
| Cohort1: CD33 CAR-T_allo-HSCT | |||||||
|
|||||||
| Cohort2: CD33 CAR-T | |||||||
|
|||||||